Dawn Brockett is Head of Community and Partnerships for CNS Summit. She is a member of the leadership team of the Changing the Norm initiative of the Decentralized Trials & Research Alliance (DTRA). She is a patient advisor on an Anorexia Nervosa trial and adjunct faculty at Boise State University in the School of Public Service. She worked on the commercial side of Biopharma for Forest-Allergan and Sanofi. A lover of theatre, she is delighted to serve on the Board of Directors for the Idaho Shakespeare Festival.